JDCA One Year Later: Looking Back at Our Initial Report
It has been just over a year since the JDCA published its first ever report, which feels like an appropriate time to revisit how we started and take a look back at our founding beliefs.
As an introductory piece, the Breaking the Glass report was a little bit longer than our typical research reports. It presented an in-depth preface to explain why our organization was founded, what we are hoping to improve within the diabetes non-profit industry, and what our ultimate goal is (to direct donor contributions toward a Practical Cure for type 1 diabetes).
The conclusions that we formed included:
• Under the existing system, it’s unclear when, if ever, a Practical Cure will be developed.
• Funding allocations and priorities of the major charities could be better aligned with the intentions of donors.
• To re-align funding allocations with donor intentions, it is necessary for donors to assert their desire to fund work that can result in a cure.
• A coalition of cure-seeking donors can present a unified voice to ensure that their requests are heard and drive the effort toward a cure.
Our analysis determined that it is vital to target research and set a timeline for the delivery of a Practical Cure. The report also insisted that type 1 research be separated from type 2 research, as the two are very different diseases with different treatments and causes.
Over the past year we have released over 20 research reports to provide independent research and analysis of the operations and developments of the diabetes charities. These reports are intended to empower donors and give them the tools to make informed decisions. Donors and fundraising participants are vital to the diabetes charitable and research universe- make your voice heard!
As we continue to develop our beliefs and take even deeper looks into the type 1 diabetes cure research landscape, our mission remains the same – to continue publishing independent research and help drive contributions toward a cure for people now living with type 1 diabetes.
- Stoyan
